591 related articles for article (PubMed ID: 15630672)
1. Periprocedural management of anticoagulation in patients on extended warfarin therapy.
Jafri SM; Mehta TP
Semin Thromb Hemost; 2004 Dec; 30(6):657-64. PubMed ID: 15630672
[TBL] [Abstract][Full Text] [Related]
2. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
Douketis JD; Johnson JA; Turpie AG
Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
[TBL] [Abstract][Full Text] [Related]
3. Risk of thromboembolism with short-term interruption of warfarin therapy.
Garcia DA; Regan S; Henault LE; Upadhyay A; Baker J; Othman M; Hylek EM
Arch Intern Med; 2008 Jan; 168(1):63-9. PubMed ID: 18195197
[TBL] [Abstract][Full Text] [Related]
4. Therapy Insight: management of urology patients taking long-term warfarin anticoagulation therapy.
Daniels PR
Nat Clin Pract Urol; 2005 Jul; 2(7):343-50. PubMed ID: 16474787
[TBL] [Abstract][Full Text] [Related]
5. Periprocedural thromboprophylaxis in patients receiving chronic anticoagulation therapy.
Jafri SM
Am Heart J; 2004 Jan; 147(1):3-15. PubMed ID: 14691412
[TBL] [Abstract][Full Text] [Related]
6. Comparison of safety of subcutaneous enoxaparin as outpatient anticoagulation bridging therapy in patients with a mechanical heart valve versus patients with nonvalvular atrial fibrillation.
Bui HT; Krisnaswami A; Le CU; Chan J; Shenoy BN
Am J Cardiol; 2009 Nov; 104(10):1429-33. PubMed ID: 19892063
[TBL] [Abstract][Full Text] [Related]
7. Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin.
Kovacs MJ; Kearon C; Rodger M; Anderson DR; Turpie AG; Bates SM; Desjardins L; Douketis J; Kahn SR; Solymoss S; Wells PS
Circulation; 2004 Sep; 110(12):1658-63. PubMed ID: 15364803
[TBL] [Abstract][Full Text] [Related]
8. Periprocedural anticoagulation management of patients with nonvalvular atrial fibrillation.
Wysokinski WE; McBane RD; Daniels PR; Litin SC; Hodge DO; Dowling NF; Heit JA
Mayo Clin Proc; 2008 Jun; 83(6):639-45. PubMed ID: 18533080
[TBL] [Abstract][Full Text] [Related]
9. Laparoscopic renal-adrenal surgery in patients on oral anticoagulant therapy.
Varkarakis IM; Rais-Bahrami S; Allaf ME; Lima GC; Permpongkosol S; Rao P; Jarrett TW; Kavoussi LR
J Urol; 2005 Sep; 174(3):1020-3; discussion 1023. PubMed ID: 16094036
[TBL] [Abstract][Full Text] [Related]
10. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
[TBL] [Abstract][Full Text] [Related]
11. Perioperative bleeding and thromboembolic risk during non-cardiac surgery in patients with mechanical prosthetic heart valves: an institutional review.
Carrel TP; Klingenmann W; Mohacsi PJ; Berdat P; Althaus U
J Heart Valve Dis; 1999 Jul; 8(4):392-8. PubMed ID: 10461238
[TBL] [Abstract][Full Text] [Related]
12. Periprocedural bridging anticoagulation: current perspectives.
Palaniswamy C; Selvaraj DR
Am J Ther; 2011 Jul; 18(4):e89-94. PubMed ID: 20228672
[TBL] [Abstract][Full Text] [Related]
13. Anticoagulation interruptus: not without risk.
Ezekowitz MD
Circulation; 2004 Sep; 110(12):1518-9. PubMed ID: 15381656
[No Abstract] [Full Text] [Related]
14. Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio.
Di Biase L; Burkhardt JD; Mohanty P; Sanchez J; Horton R; Gallinghouse GJ; Lakkireddy D; Verma A; Khaykin Y; Hongo R; Hao S; Beheiry S; Pelargonio G; Dello Russo A; Casella M; Santarelli P; Santangeli P; Wang P; Al-Ahmad A; Patel D; Themistoclakis S; Bonso A; Rossillo A; Corrado A; Raviele A; Cummings JE; Schweikert RA; Lewis WR; Natale A
Circulation; 2010 Jun; 121(23):2550-6. PubMed ID: 20516376
[TBL] [Abstract][Full Text] [Related]
15. Oral surgery in patients on anticoagulant treatment without therapy interruption.
Ferrieri GB; Castiglioni S; Carmagnola D; Cargnel M; Strohmenger L; Abati S
J Oral Maxillofac Surg; 2007 Jun; 65(6):1149-54. PubMed ID: 17517299
[TBL] [Abstract][Full Text] [Related]
16. Low-molecular-weight-heparins as periprocedural anticoagulation for patients on long-term warfarin therapy: a standardized bridging therapy protocol.
Jaffer AK; Ahmed M; Brotman DJ; Bragg L; Seshadri N; Qadeer MA; Klein A
J Thromb Thrombolysis; 2005 Aug; 20(1):11-6. PubMed ID: 16133889
[TBL] [Abstract][Full Text] [Related]
17. Management of anticoagulation in patients with prosthetic heart valves undergoing oral and maxillofacial operations.
Webster K; Wilde J
Br J Oral Maxillofac Surg; 2000 Apr; 38(2):124-6. PubMed ID: 10864707
[TBL] [Abstract][Full Text] [Related]
18. Perioperative management of long-term anticoagulation.
Kearon C
Semin Thromb Hemost; 1998; 24 Suppl 1():77-83. PubMed ID: 9840696
[TBL] [Abstract][Full Text] [Related]
19. Peri-procedural anticoagulation management of mechanical prosthetic heart valve patients.
Daniels PR; McBane RD; Litin SC; Ward SA; Hodge DO; Dowling NF; Heit JA
Thromb Res; 2009 Jul; 124(3):300-5. PubMed ID: 19232682
[TBL] [Abstract][Full Text] [Related]
20. Cardiac resynchronization therapy device implantation in patients with therapeutic international normalized ratios.
Ghanbari H; Feldman D; Schmidt M; Ottino J; Machado C; Akoum N; Wall TS; Daccarett M
Pacing Clin Electrophysiol; 2010 Apr; 33(4):400-6. PubMed ID: 20180915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]